These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23496375)

  • 1. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
    Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?
    Izumikawa K; Tashiro T; Tashiro M; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Hayashi T; Yanagihara K; Nagayasu T; Kohno S
    J Infect Chemother; 2014 Mar; 20(3):208-12. PubMed ID: 24477329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
    Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Aggarwal AN; Chakrabarti A; Choudhary H; Garg M; Agarwal R
    Lancet Infect Dis; 2022 Jul; 22(7):1052-1061. PubMed ID: 35429465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.
    Ray A; Manikanta J; Singh K; Gabra P; Vyas S; Singh G; Xess I; Sethi P; Meena VP; Soneja M; Sinha S; Wig N; Kabra SK
    Mycoses; 2021 Sep; 64(9):1038-1044. PubMed ID: 34058036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S; Ohnishi R; Suzuki T; Sano K; Kato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and Safety of Inhaled Itraconazole Nanosuspension in a Model Pulmonary Aspergillus fumigatus Infection in Inoculated Young Quails.
    Wlaź P; Knaga S; Kasperek K; Wlaź A; Poleszak E; Jeżewska-Witkowska G; Winiarczyk S; Wyska E; Heinekamp T; Rundfeldt C
    Mycopathologia; 2015 Aug; 180(1-2):35-42. PubMed ID: 25790942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
    Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
    Cadranel J; Philippe B; Hennequin C; Bergeron A; Bergot E; Bourdin A; Cottin V; Jeanfaivre T; Godet C; Pineau M; Germaud P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3231-9. PubMed ID: 22782438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
    Bongomin F; Harris C; Hayes G; Kosmidis C; Denning DW
    PLoS One; 2018; 13(4):e0193732. PubMed ID: 29634721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Olum R; Baluku JB; Kazibwe A; Russell L; Bongomin F
    PLoS One; 2020; 15(10):e0240374. PubMed ID: 33052954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.
    Felton TW; Baxter C; Moore CB; Roberts SA; Hope WW; Denning DW
    Clin Infect Dis; 2010 Dec; 51(12):1383-91. PubMed ID: 21054179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
    Tani S; Tomioka H; Tsuchimoto K; Kaneda T; Kubota M; Kaneko M; Fujii H
    Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):997-1002. PubMed ID: 19195200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in chronic pulmonary aspergillosis.
    Izumikawa K
    Respir Investig; 2016 Mar; 54(2):85-91. PubMed ID: 26879477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Itraconazole: a new drug-related cause of hypertension].
    Denolle T; Azizi M; Massart C; Zennaro MC
    Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):213-5. PubMed ID: 24952675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.
    Niu Y; Li J; Shui W; Li D; Yu C; Fu X; Zhang C
    J Mycol Med; 2020 Dec; 30(4):101041. PubMed ID: 32950379
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.